HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Like Kentucky’s Senior Senator, Paul Hoists Legislative Flag For US Hemp Industry Growth

Executive Summary

Sen. Paul’s HEMP Act would raise from 0.3% to 1% the level of THC by dry weight in hemp under the 2018 farm bill. The bill also would require testing for THC levels in final products containing cannabinoids and other hemp-derived ingredients rather than within 15 days of harvest.

You may also be interested in...



For US Hemp Market, Sen. Paul Remains Mobile

Kentucky's junior senator re-introduced legislation to raise from 0.3% to 1% the level of THC by dry weight that Congress defined as legal hemp in the 2018 farm bill.

US Senate Appetite For Lawful Use Of Cannabinoids Includes Food On Top Of Supplements

Senate bill introduced on 19 May, unlike a House bill introduced in February, would direct FDA to allow using hemp-derived cannabinoids in food products as well as supplements. However, neither bill includes language on setting a safe daily level that some industry stakeholders argue is needed.

In Year Made Unusual By COVID-19, Still More Unusual Consumer Health Claims Surface In US

An ultraviolet lamp marketer was dinged by industry self-regulation for COVID-19 claims; the largest US natural  food grocery chain had one too many undeclared allergens for the FDA's liking; and warnings note cannabidiol-containing eye drops, nasal sprays and inhalers promoted with drug claims.

Related Content

Topics

UsernamePublicRestriction

Register

RS150831

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel